Table 1. General Characteristics of the Included Studies

Author(year) Sample size(T:C) Male/Female Mean age(years)(range) Mean duration of disease(range) Onset duration Degree of deafness
Luo(2024)28) 120(60:60) T: 33/27C: 35/25 T: 54±4(18-60)C: 54±4(18-60) T: 4.41±1.08(d)(2-7d)C: 4.36±1.15(d)(2-7d) 2-7d NR
Zhang(2024)29) 66(33:33) T: 13/20C: 10/23 T: 53.00(47-58)C: 56.00(44-62) T: 22(d)(15-30d)C: 30(d)(20-30d) 15-90d NR
Jiang(2023)30) 132(66:66) T: 22/44C: 28/38 T: 48.12±12.74C: 44.21±12.17 NR Within 2m NR
Tao(2023)31) 80(40:40)Drop out 1:1 T: 19/20C: 17/22 T: 47±12(19-59)C: 47±13(20-58) T: 6.3±2.3(d)(2-10d)C: 5.9±2.1(d)(2-9d) Within 10d NR
Wei(2022)32) 60(30:30) T : 19/11C : 18/12 T : 34.82±16.21(18-70)C : 35.43±14.56(18-70) T : 12.08±3.54(d)(3-29d)C : 11.25±4.32(d)(3-28d) NR NR
Liang(2021)33) 90(30:30:30) T1: 12/18T2: 15/15C: 14/16 T1: 32.30±6.02T2: 33.70±5.85C: 32.70±6.20 T1: 8.20±3.61(d)T2: 8.00±3.58(d)C: 7.90±3.69(d) 3h-2w NR
Jiang(2021)34) 118(30:30:31:27)Drop out 1:0:0:1 T1: 12/17T2: 15/15T3: 17/14C: 16/10 T1: 53±11(23-74)T2: 51±13(22-72)T3: 52±13(26-74)C: 52±13(22-74) T1: 12.1±7.3(d) (0.5-29d)T2: 10.2±5.1(d)(1-20d)T3: 10.4±5.1(d)(1-20d)C: 11.3±6.2(d)(1-20d) Within 1m Mild/Moderate/Severe/Extremly heavyT1:8/8/9/4T2:1/10/6/13T3:6/14/4/7C:5/7/8/6
Sun(2021)35) 100(50:50) T : 25/25C : 20/30 T : 45.8±8.4(30-70)C : 45.2±7.8(32-69) T : 8.3±2.8(m)(5-12m)C : 7.3±3.5(m)(3-12m) NR Mild/Moderate/SevereT:8/30/12C:8/35/5
Zhang(2020)36) 100(50:50) T: 24/26C: 22/28 T: 39.96±12.72C: 41.34±11.55 T: 7.41±2.62(d)C: 7.27±2.25(d) 2-14d Mild/Moderate/Severe/Extremly heavy/Totally deafT:17/15/13/3/2C:19/16/11/2/2Low/High/FullT:20/19/11C:24/17/9
Sheng(2020)37) 78(39:39) T: 19/20C: 21/18 T: 40±1 (20-66)C: 42±13(21-68) T: 20.4±3.5(d) (14-28d)C: 20.6±3.5(d)(14-28d) 14-28d Moderate/Moderate-severe/SevereT:20/14/5C:17/21/1
Fan(2020)38) 105(35:35:35) T1: 18/17T2: 16/19C: 17/18 T1: 45.94±10.47T2: 47.06±9.53C: 48.06±11.45 T1: 7.46±3.85(d)T2: 6.91±3.51(d)C: 6.31±3.78(d) Within 2w NR
Ju(2020)39) 72(36:36) T: -C: - T: 37.89±0.06(18-72)C: 36.36±0.03(18-72) NR NR NR
Lu(2019)40) 300(150:150) T: 82/68C: 80/70 T: 41.82±5.48C: 42.19±5.63 NR NR NR
Gao(2019)41) 110(55:55) T: 29/26C: 30/25 T: 46.62±6.25(18-68)C: 46.78±6.37(19-70) NR NR NR
Gong(2018)42) 37(20:17) 25/17 A; 53.4±10.3(45-70) A: 1d-3m NR NR
Zhao(2017)43) 60(30:30) T: 19/11C: 20/10 T: 57±13C: 58±12 T : 47.67±25.53(h)C: 48.53±24.44(h) NR Mild/Moderate/SevereT:12/12/6C:11/12/7
Liang(2017)44) 103(51:52) T: 17/34C: 19/33 T: 32.30±4.70C: 32.70±3.90 T: 8.20±3.60(d)C: 7.90±3.70(d) Within 2w NR
Guo(2016)45) 60(30:30) T: 31/32C: 21/24 T: 38.5±11.7C: 39.1±10.8 T: 5.3±2.6(d)(1-12d)C: 5.4±2.7(d)(1-13d) Within 2w NR
Yang(2016)46) 90(45:45) T: 21/24C: 21/24 T: 37.98±11.15(18-68)C: 37.05±10.72(18-65) T: 14.63±5.62(d)(2-26d)C: 13.72±4.23(d)(1-25d) NR NR
Liu(2015)47) 60(30:30) T: 18/12C: 21/9 A; 46(17-65) A: 3d-1m NR NR
Huang(2014)48) 112(59:53) T : 33/26C : 29/24 T: 37.0±5.6C: 38.0±4.9 T :18.0±3.5(d)(10-30d)C: 19.0±4.2(d)(10-30d) Within 30d NR
Liang(2014)49) 60(30:30) T: 14/16C: 13/17 T: 33.80±12.03C: 31.53±11.69 T: 3.82±1.10(d)C: 3.72±1.08(d) Within 2w Mild/Moderate/Moderate to severe/SevereT: 5/9/11/5C: 6/8/10/6
Xu(2013)50) 62(30:32) T: 19/11C: 20/12 T: 44.2±2.4(23-71)C: 45.5±2.0(16-73) T: 1d-5yC: 2d-4y NR Mild/Moderate/Moderate to severe/Severe/Hearing lossT: 2/5/11/7/4C: 1/11/11/7/2
Luo(2012)51) 188(74:56:58) T1: 38/36T2: 28/28C: 28/30 T1: 49±7(31-61)T2: 49±6(35-63)C: 48±6(32-58) T1: 13.2±3.8(d)(3-22d)T2: 12.2±3.9(d)(1-20d)C: 12.7±3.9(d)(2-21d) Within 1m Mild/Moderate/SevereT1: 24/25/25T2: 19/20/17C: 20/20/18
Qiu(2012)52) 60(30:30)Drop out 2:0Affected ear 34:32 T: 6/22C: 10/20 T: 42.6±13.5(14-62)C: 42.8±13.4(15-64) T: 4.5±19.5(d)(1-45d)C: 7.0±5.2(d)(1-15d) NR NR
Chen(2011)53) 100(50:50) T: 26/24C: 24/26 T: 33±11C: 32±11 <1d/1-7d/>7dT: 17/26/7C: 19/23/8 NR Mild/Moderate/Moderate to severe/Severe/Hearing lossT:6/22/16/5/1C:7/21/15/6/1
Wu(2010)54) Affected ear 69:53 T: 44/25C: 32/21 T: 15-77C: 15-77 NR NR Mild/Moderate/Moderate to severe/Severe/Hearing lossT: 11/12/18/15/13C: 8/10/15/10/10
Luo(2009)55) 60(30:30) T: 15/15C: 15/15 T: 50.3±4.4C: 51.2±5.1 T: 2.1±0.1(w)C: 2.2±0.2(w)A: 1d-4w NR NR
T: Treatment group; C: Control group; NR: Not reported; h: Hours; d: Days; w: Weeks; m; Months; y: year; A: All group